Biocon
India's largest and fully-integrated, innovation-led biopharmaceutical company.
Launch date
Employees
Market cap
CAD8.3b
Enterprise valuation
CAD10.8b (Public information from Sep 2024)
Share price
INR363.54999 BIOCON.NS
Bengaluru Karnataka (HQ)
Financials
Estimates*
| INR | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Revenues | 69.7b | 80.2b | 111.7b | 142.0b | 155.2b | 185.0b | 216.0b |
| % growth | 12 % | 15 % | 39 % | 27 % | 9 % | 19 % | 17 % |
| EBITDA | 16.8b | 19.6b | 27.2b | 30.3b | 34.2b | 44.7b | 53.5b |
| % EBITDA margin | 24 % | 24 % | 24 % | 21 % | 22 % | 24 % | 25 % |
| Profit | 7.4b | 6.5b | 4.6b | 10.2b | 12.0b | 12.8b | 17.7b |
| % profit margin | 11 % | 8 % | 4 % | 7 % | 8 % | 7 % | 8 % |
| EV / revenue | 6.9x | 5.3x | 3.6x | 3.2x | 3.6x | 3.0x | 2.5x |
| EV / EBITDA | 28.7x | 21.4x | 14.7x | 14.8x | 16.4x | 12.3x | 10.1x |
| R&D budget | 4.0b | 5.0b | 6.1b | 8.0b | - | - | - |
| R&D % of revenue | 6 % | 6 % | 5 % | 6 % | - | - | - |
Source: Dealroom estimates
Related Content
Recent News about Biocon
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
